The natural history of Alzheimer's disease

Dementia 3Ed

Volumn , Issue , 2005, Pages 376-386

  Corey Bloom, Jody ^a   Fleisher, Adam S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748417713     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (134)

1. Aevarsson O, Svanborg A, Skoog I. (1998) Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Archives of Neurology 55: 1226-1232
2. Aguero-Torres H, Fratiglioni L, Guo Z et al. (1998) Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. Journal of the American Geriatrics Society 46: 444-452
3. Aisen PS, Schafer KA, Grundman M et al. (2003) Effects of Rofecoxib and Naproxen vs placebo in Alzheimer's disease progression. JAMA 289:2819-2826
4. Backman L, Jones S, Small B et al. (2003) Rate of cognitive decline in preclinical Alzheimer's disease: The role of comorbidity. Journals of Gerontology Series B. Psychological Sciences and Social Sciences 58: 228-236
5. Bakchine S, Lacomblez L, Palisson E et al. (1989) Relationship between primitive reflexes, extrapyramidal signs, reflexive apraxia, and severity of cognitive impairment in dementia of the Alzheimer type. Acta Neurologica Scandinavica 79: 38-46
6. Barclay LL, Zemcov A, Blass JP, Sansone J. (1985) Survival in Alzheimer's disease and vascular dementias. Neurology 35: 834-840
7. Becker J, Boller F, Lopez O et al. (1994) The natural history of Alzheimer's disease: description of study cohort and accuracy of diagnosis. Archives of Neurology 51: 585-594
8. Becker JT, Huff FJ, Nebes RD et al. (1988) Neuropsychological function in Alzheimer's disease: pattern of impairment and rates of progression. Archives of Neurology 45: 263-268
9. Berg L, Miller JP, Storandt M et al. (1988) Mild senile dementia of the Alzheimer type: 2. Longitudinal assessment. Annals of Neurology 23:477-484
10. Bianchetti A, Scuratti A, Zanetti O et al. (1995) Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia 6: 108-112
11. Bondi M, Salmon D, Butters N. (1994) Neuropsychological features of memory disorders in Alzheimer disease. In: RD Terry, R Katzman, KL Bick (eds), Alzheimer disease 1st edition. Philadelphia, Lippincott-Raven Publishers, pp. 41-64
12. Bowen J, Malter A, Sheppard L et al. (1996) Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 47:433-439
13. Bracco L, Gallato R, Grigoletto F et al. (1994) Factors affecting course and survival in Alzheimer's Disease. A nine-year longitudinal study. Archives of Neurology 51: 1213-1219
14. Brookmeyer R, Gray S, Kawas C. (1998) Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. American Journal of Public Health 88: 1337-1342
15. Brouwers P, Cox D, Martin A, Chase T, Fedio P. (1984) Differential perceptual-spatial impairment in Huntington's and Alzheimer's dementias. Archives of Neurology 41: 1073-1076
16. Burns A, Jacoby R, Levy R. (1990) Psychiatric phenomena in Alzheimer's disease. IV. Disorders of behavior. British Journal of Psychiatry 157: 86-94
17. Burns A, Jacoby R, Levy R. (1991) Progression of cognitive impairment in Alzheimer's disease. Journal of the American Geriatrics Society 39: 34-45
18. Chen JY, Stern Y, Sano M, Mayeux R. (1991) Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. Archives of Neurology 48: 1141-1143
19. Chui H, Lyness S, Sobel E, Schneider L. (1994) Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease. Archives of Neurology 51: 676-681
20. Claus J, van Fool W, Teunisse S et al. (1998) Predicting survival in patients with early Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 9: 284-93
21. Cook SE, Miyahara S, Bacanu SA et al. (2003) Psychotic symptoms in Alzheimer disease: evidence for subtypes. American Journal of Geriatric Psychiatry 11: 406-413
22. Corder E, Saunders A, Strittmatter W et al. (1995) Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 45: 1323-1328
23. Corey-Bloom J, Galasko D, Hofstetter C et al. (1993) Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. Journal of the American Geriatrics Society 41: 31-37
24. Craft S, Teri L, Edland S et al. (1998). Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease. Neurology 51: 149-153
25. Cummings JL and Cole G. (2002) Alzheimer disease. JAMA 287: 2335-2338
26. Cummings JL, Benson DF, Hill MA, Read S. (1985) Aphasia in dementia of the Alzheimer type. Neurology 35: 394-397
27. Cummings JL, Miller B, Hill MA, Neshkes R. (1987) Neuropsychiatrie aspects of multi-infarct dementia and dementia of the Alzheimer type. Archives of Neurology 44: 389-393
28. Dal Forno G, Carson KA, Brookmeyer R et al. (2002) APoE genotype and Survival in Men and Women with Alzheimer's Disease. Neurology 58:1045-1050
29. Drachman DA, O'Donnell BF, Lew RA, Swearer JM. (1990) The prognosis in Alzheimer's disease: 'How Far' rather than 'How Fast' best predicts the course. Archives of Neurology 47: 851-856
30. Drevets WC and Rubin EH. (1989) Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biological Psychiatry 25: 39-48
31. Eaker ED, Vierkant RA, Mickel SF. (2002) Predictors of nursing home admission and/or death in incident Alzheimer's disease and other dementia cases compared to controls: a population-based study. Journal of Clinical Epidemiology 55: 462-468
32. Evans DA, Smith LA, Scherr PA et al. (1991) Risk of death from Alzheimer's disease in a community population of older persons. American Journal of Epidemiology 134: 403-412
33. Filley CM, Brownell H, Albert ML. (1985) Education provides no protection against Alzheimer's disease. Neurology 35: 1781-1784
34. Frisoni G, Govoni S, Geroldi C et al. (1995) Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Annals of Neurology 37: 596-604
35. Galasko D, Klauber MR, Hofstetter CR et al. (1990) The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Archives of Neurology 47: 49-52
36. Gambassi G, Landi F, Lapane KL et al. (1999) Predictors of mortality in patients with Alzheimer's disease living in nursing homes. Journal of Neurology, Neurosurgery, and Psychiatry 67: 59-65
37. Gaugler JE, Kane RL, Kane RA et al. (2003) Caregiving and institutionalization of cognitively impaired older people: utilizing dynamic predictors of change. The Gerontologist 43: 219-229
38. Geerlings M, Deeg D, Schmand B et al. (1997) Increased risk of mortality in Alzheimer's disease patients with higher education? A replication study. Neurology 49: 798-802
39. Gomez-Isla T, West H, Rebeck G et al. (1996) Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Annals of Neurology 39: 62-70
40. Growdon J, Locascio J, Corkin S et al. (1996) Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 47: 444-448
41. Haan MN, Jagust WJ, Galasko D, Kaye J. (2002) Effect of extrapyramidal and Lewy bodies on survival in patients with Alzheimer disease. Archives of Neurology 59: 588-593
42. Haskell S, Richardson E, Horwitz R. (1997) The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. Journal of Clinical Epidemiology 50: 1249-1264
43. Haupt M and Kurz A. (1993) Predictors of nursing home placement in patients with Alzheimer's disease. International Journal of Geriatric Psychiatry 8: 741-746
44. Hauser WA, Morris ML, Heston LL, Anderson VE. (1986) Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36: 1226-1230
45. Helmes E and Ostbye T. (2002) Beyond memory impairment: cognitive changes in Alzheimer's disease. Archives of Clinical Neuropsychology 17:179-193
46. Heston LL, Mastri AR, Anderson VE, White J. (1981) Dementia of the Alzheimer type: clinical genetics, natural history, and associated conditions. Archives of General Psychiatry 31: 1085-1090
47. Heyman A, Wilkinson WE, Hurwitz BJ et al. (1987) Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 37: 980-984
48. Heyman A, Peterson B, Fillenbaum G, Pieper C. (1996) The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: demographic and clinical predictors of survival in patients with Alzheimer disease. Neurology 46: 656-660
49. Heyman A, Peterson B, Cillenbaum G, Pieper C. (1997) Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII. Neurology 48: 1304-1309
50. Hier D, Warach J, Gorelick P, Thomas J. (1989) Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. Archives of Neurology 46: 1213-1216
51. Hirono N, Hashimoto M, Yasuda M et al. (2003) Accelerated memory decline in Alzheimer's disease with apolipoprotein, 4 allele. Journal of Neuropsychiatry and Clinical Neuroscience 15: 354-358
52. Hooker K, Bowman SR, Coehlo DP et al. (2002) Behavioral change in persons with dementia: relationships with mental and physical health of caregivers. Journal of Gerontology. Series B, Psychological Sciences and Social Sciences 57: P453-P460
53. Huff FJ, Belle SH, Shim YK et al. (1990) Prevalence and prognostic value of neurologic abnormalities in Alzheimer's disease. Dementia 1: 32-40
54. Hughes CP, Berg L, Danziger WL et al. (1982) A new clinical scale for the staging of dementia. British Journal of Psychiatry 140: 566-572
55. Hutton JT, Dippel RL, Loewenson RB et al. (1985) Predictors of nursing home placement of patients with Alzheimer's disease. Texas Medicine 81: 40-43
56. Jacobs D, Sano M, Marder K et al. (1994) Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 44: 1215-1220
57. Jagger C, Clarke M, Stone A. (1995) Predictors of survival with Alzheimer's disease: a community-based study. Psychological Medicine 25: 171-177
58. Jorm AF, Korten AE, Henderson AS. (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatrica Scandinavica 76: 465-479
59. Jost B and Grossberg G. (1995) The natural history of Alzheimer's disease: a brain bank study. Journal of the American Geriatrics Society 43: 1248-1255
60. Jost B and Grossberg G. (1996) The evolution of psychiatric symptoms in Alzheimer's disease. Journal of the American Geriatrics Society 44: 1078-1081
61. Katzman R. (1976) The prevalence and malignancy of Alzheimer disease: a major killer. Archives of Neurology 33: 217-218
62. Katzman R, Brown T, Thal LJ et al. (1988) Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Annals of Neurology 34: 384-389
63. Kavcic V and Duffy CJ. (2003) Attentional dynamics and visual perception: mechanisms of spatial disorientation in Alzheimer's disease. Brain 126: 1173-1181
64. Knopman DS, Kitto J, Deinard S, Heiring J. (1988) Longitudinal study of death and institutionalization in patients with primary degenerative dementia. Journal of the American Geriatrics Society 36: 108-112
65. Kramer-Ginsberg E, Mohs RC, Aryan M et al. (1988) Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report. Psychopharmacology Bulletin 24: 458-462
66. Kurz A, Egensperger R, Haupt M et al. (1996) Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 47: 440-443
67. Lapane KL, Gambassi G, Landi F et al. (2001) Gender differences in predictors of mortality in nursing home residents with AD. Neurology 56: 650-654
68. Lazarus LW, Newton N, Cohler B et al. (1987) Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. American Journal of Psychiatry 144: 41-45
69. Lee J, Olichney JM, Hansen LA et al. (2000) Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Archives of Neurology 57: 1474-1479
70. Lopez OL, Boller F, Becker JT et al. (1990) Alzheimer's disease and depression: neuropsychological impairment and progression of the illness. American Journal of Psychiatry 147: 855-860
71. Lopez O, Wisniewski S, Becker J et al. (1997) Extrapyramidal signs in patients with probable Alzheimer's disease. Neurology 54: 969-975
72. Lopez O, Wisniewski SR, Becker JT et al. (1999) Psychiatric medications and abnormal behavior as predictors of progression in probable Alzheimer's disease. Archives of Neurology 56: 1266-1272
73. Lopez O, Wisniewski SR, Hamilton RL et al. (2000) Predictors of progression in patients with AD and Lewy bodies. Neurology 54: 1774-1779
74. Lucca U, Comelli M, Tettamanti M et al. (1993) Rate of progression and prognostic factors in Alzheimer's disease: a prospective study. Journal of the American Geriatrics Society 41: 45-49
75. Lyketsos CG, Lopez O, Jones B et al. (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 288:1475-1483
76. McGonigal G, McQuade CA, Thomas BM, Whalley LJ. (1992) Survival in presenile Alzheimer's and multi-infarct dementias. Neuroepidemiology 11: 121-126
77. Martin D, Miller J, Kapoor W et al. (1987) A controlled study of survival with dementia. Archives of Neurology 44: 1122-1126
78. Mayeux RT, Stern Y, Spanton S. (1985) Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 35: 453-461
79. Mega MS, Masterman DM, O'Connor SM et al. (1999) The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Archives of Neurology 56: 1388-1393
80. Miller T, Tinklenberg J, Brooks J, Yesavage J. (1991) Cognitive decline in patients with Alzheimer's disease: differences in patients with and without extrapyramidal signs. Alzheimer Disease and Associated Disorders 5: 251-256
81. Molsa P, Marttila R, Rinne U. (1995) Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurologica Scandinavica 91: 159-164
82. Molsa PK, Marttila RJ, Rinne UK. (1986) Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurologica Scandinavica 74: 103-107
83. Moritz D, Fox P, Luscombe F, Kraemer H. (1997) Neurological predictors of mortality in patients with Alzheimer disease in California. Archives of Neurology 54: 878-885
84. Morris J. (1997) Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. International Psychogeriatrics 9 (Suppl. 1): 173-176
85. Morris J, Edland S, Clark C et al. (1993) The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 43: 2457-2465
86. Mortimer J, Ebbitt B, Jun S-P, Finch M. (1992) Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 42: 1689-1696
87. Mungas D, Reed BR, Ellis WG, Jagust W. (2001) The effects of aging on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Archives of Neurology 58: 1243-1247
88. Murdoch BE and Chenery HJ. (1987) Language disorders in dementia of the Alzheimer type. Brain and Language 31: 122-137
89. Olichney JM, Galasko D, Salmon DP et al. (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 51:351-357
90. Ortof E and Crystal HA. (1989) Rate of progression of Alzheimer's disease. Journal of the American Geriatrics Society 37: 511-514
91. Pearson JL, Teri L, Reifler BF, Raskind MA. (1989) Functional status and cognitive impairment in Alzheimer's patients with and without depression. Journal of the American Geriatrics Society 37: 1117-1121
92. Rapcsak SZ, Croswell SC, Rubens AB. (1989) Apraxia in Alzheimer's disease. Neurology 39: 664-668
93. Reisberg B, Ferris S, de Leon MJ, Crook T. (1982) The Global Deterioration Scale (GDS): an instrument for the assessment of primary degenerative dementia (PDD). American Journal of Psychiatry 139: 1136-1139
94. Reisberg B, Ferris SH, Steinberg G et al. (1986) Longitudinal course of normal aging and progressive dementia of the Alzheimer's type: a prospective study of 106 subjects over a 3.6 year mean interval. Progress in Neuro-Psychopharmacology and Biological Psychiatry 10: 571-578
95. Reisberg B, Borenstein J, Salob SP et al. (1987) Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. Journal of Clinical Psychiatry 48: 9-15
96. Reisberg B, Franssen E, Sclan SG et al. (1989) Stage specific incidence of potentially remediable behavioral symptoms in aging and Alzheimer disease. Bulletin of Clinical Neurosciences 54: 95-112
97. Reisberg B, Ferris S, Franssen E et al. (1996) Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study. International Psychogeriatrics 8: 291-311
98. Rich J, Rasmusson D, Folstein M. (1995) Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 45: 51-55
99. Rockwood K. (2002) Use of lipid lowering agents, indication bias, and the risk of dementia in community dwelling elderly people. Archives of Neurology 59: 223-227
100. Rosen J and Zubenko GS. (1991) Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biological Psychiatry 29: 224-232
101. Rosen WG, Mohs RC, Davis KL. (1984) A new rating scale for Alzheimer's disease. American Journal of Psychiatry 141: 1356-1364
102. Roth M, Tym E, Mountjoy CQ et al. (1986) CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry 149: 698-709
103. Salmon DP, Thal LJ, Butters N, Heindel WC. (1990) Longitudinal evaluation of dementia of the Alzheimer type: a comparison of three standardized mental status examinations. Neurology 40: 1225-1230
104. Samson W, van Duijn C, Hop W, Hofman A. (1996) Clinical features and mortality in patients with early-onset Alzheimer's disease. European Neurology 36: 103-106
105. Sano M, Ernesto C, Thomas RG et al. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as a treatment for Alzheimer's disease. New England Journal of Medicine 336: 1216-1222
106. Schoenberg B, Kokmen E, Okazaki H. (1987) Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Annals of Neurology 22: 724-749
107. Stern Y, Mayeux R, Sano M et al. (1987) Predictors of disease course in patients with probable Alzheimer's disease. Neurology 37: 1649-1653
108. Stern Y, Hesdorffer D, Sano M, Mayeux R. (1990) Measurement and prediction of functional capacity in Alzheimer's disease. Neurology 40: 8-14
109. Stern Y, Albert M, Brandt J et al. (1994) Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission and death in Alzheimer's disease. Neurology 44:2300-2307
110. Stern Y, Tang M, Denaro J, Mayeux R. (1995) Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Annals of Neurology 37: 590-595
111. Stern Y, Brandt J, Albert M, Jacobs D et al. (1997) The absence of an apolipoprotein epsilon 4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology 41: 615-620
112. Storandt M, Grant EA, Miller JP, Morris JC. (2002) Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 59: 1034-1041
113. Sullivan EV, Corkin S, Growden JH. (1986) Verbal and non-verbal shortterm memory in patients with Alzheimer's disease and in healthy elderly subjects. Developmental Neuropsychology 2: 387-400
114. Swanwick GRJ, Coen RF, Coakley D, Lawlor BA. (1998) Assessment of progression and prognosis in 'possible' and 'probable' Alzheimer's disease. International Journal of Geriatric Psychiatry 13: 331-335
115. Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. (1988) Troublesome and disruptive behaviors in dementia. Journal of the American Geriatrics Society 36: 784-790
116. Tariot P, Mack J, Patterson M et al. (1995) The Behavior Rating Scale for Dementia of the Consortium to establish a registry for Alzheimer's disease. American Journal of Psychiatry 152: 1349-1357
117. Teri L, Larson EB, Reifler BV. (1988) Behavioral disturbances in dementia of the Alzheimer's type. Journal of the American Geriatrics Society 36: 1-6
118. Teri L, Hughes JP, Larson EB. (1990) Cognitive deterioration in Alzheimer's disease: behavioral and health factors. Journal of Gerontology 45: P58-P63
119. Teri L, McCurry S, Edland S et al. (1995) Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. Journal of Gerontology 50A, M49-M55
120. Thal LJ, Grundman M, Klauber MR. (1988) Dementia: characteristics of a referral population and factors associated with progression. Neurology 38: 1083-1090
121. Thal LJ, Calvani M, Amato A, Carta A. (2000) A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. Neurology 55: 805-810
122. Thal LJ, Thomas RG, Mulnard R et al. (2003) Estrogen levels do not correlate with improvement in cognition. Archives of Neurology 60:209-212
123. Tilvis R, Strandberg T, Juva K. (1998) Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. Journal of the American Geriatrics Society 46: 712-715
124. Tschampa HJ, Neumann M, Zerr I et al. (2001) Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery, and Psychiatry 71: 33-39
125. Uhlman RF, Larson EB, Koepsell TD. (1986) Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type. Journal of the American Geriatrics Society 34: 207-210
126. Ueki A, Shinjo H, Shimode H et al. (2001) Factors associated with mortality in patients with early-onset Alzheimer's disease: a five-year longitudinal study. International Journal of Geriatric Psychiatry 16: 810-815
127. van Dijk P, Dippel D, Habbema J. (1991) Survivals of patients with dementia. Journal of the American Geriatrics Society 39: 603-610
128. Walsh JS, Welch HG, Larson EB. (1990) Survival of outpatients with Alzheimer-type dementia. Annals of Internal Medicine 113: 429-434
129. White H, Pieper C, Schmader K, Fillenbaum G. (1996) Weight change in Alzheimer's disease. Journal of the American Geriatrics Society 44:265-272
130. Wilson RS, Bacon LD, Fox JH, Kaszniak AW. (1983) Primary and secondary memory in dementia of the Alzheimer type. Journal of Clinical Neuropsychology 5: 337-344
131. Winblad, B, Engedal, K, Soininen. H et al. (2001) A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57(3), 489-495
132. Wragg RE and Jeste DV. (1989) Overview of depression and psychosis in Alzheimer's disease. American Journal of Psychiatry 146: 577-587
133. Yaffe K, Sawaya G, Lieberburg I, Grady D. (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279: 688-695
134. Yesavage JA, Poulsen AB, Sheikh J, Tanke E. (1988) Rates of change of common measures of impairment in senile dementia of the Alzheimer type. Psychopharmacology Bulletin 24: 531-534